Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment

被引:98
作者
Dhaliwal, Gurbir [1 ]
Mukherjee, Debabrata [1 ]
机构
[1] Univ Kentucky, Gill Heart Inst, Dept Internal Med, Lexington, KY 40506 USA
关键词
Ankle-brachial index; Claudication; Peripheral arterial disease; Vascular disease;
D O I
10.1055/s-0031-1278244
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Lower extremity peripheral arterial disease (PAD) affects approximately 10% of the American population, with 30% to 40% of these patients presenting with claudication symptoms. The prevalence of PAD increases with age and the number of vascular risk factors. More importantly, it is a marker of atherosclerotic disease burden, and is associated with increased mortality from cardiovascular and cerebrovascular causes. There have been recent advances in noninvasive imaging, endovascular approaches for revascularization, and aggressive risk factor management for prevention of cardiac and cerebrovascular complications in PAD. There is now a trend toward aggressive risk factor modification and endovascular revascularization for most patients, with surgical interventions reserved for certain situations only. In the present article, a systematic review is presented, focusing on the key aspects of the disease epidemiology, presentation, natural history, diagnosis and available management options.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 96 条
[21]   THE PREVALENCE OF PERIPHERAL ARTERIAL-DISEASE IN A DEFINED POPULATION [J].
CRIQUI, MH ;
FRONEK, A ;
BARRETTCONNOR, E ;
KLAUBER, MR ;
GABRIEL, S ;
GOODMAN, D .
CIRCULATION, 1985, 71 (03) :510-515
[22]   A comparison of cilostazol and pentoxifylline for treating intermittent claudication [J].
Dawson, DL ;
Cutler, BS ;
Hiatt, WR ;
Hobson, RW ;
Martin, JD ;
Bortey, EB ;
Forbes, WP ;
Strandness, DE .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (07) :523-530
[23]   Cilostazol has beneficial effects in treatment of intermittent claudication - Results from a multicenter, randomized, prospective, double-blind trial [J].
Dawson, DL ;
Cutler, BS ;
Meissner, MH ;
Strandness, DE .
CIRCULATION, 1998, 98 (07) :678-686
[24]   Acute occlusion of popliteal and/or tibial arteries:: the value of percutaneous treatment [J].
Desgranges, P ;
Kobeiter, H ;
d'Audiffret, A ;
Mellière, D ;
Mathieu, D ;
Becquemin, JP .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2000, 20 (02) :138-145
[25]  
Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894
[26]   Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia - Five-year follow-up [J].
Dorros, G ;
Jaff, MR ;
Dorros, AM ;
Mathiak, LM ;
He, T .
CIRCULATION, 2001, 104 (17) :2057-2062
[27]  
Dorros G, CATHET CARDIOVASC DI
[28]   Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease [J].
Duda, SH ;
Pusich, B ;
Richter, G ;
Landwehr, P ;
Oliva, VL ;
Tielbeek, A ;
Wiesinger, B ;
Hak, JB ;
Tielemans, H ;
Ziemer, G ;
Cristea, E ;
Lansky, A ;
Bérégi, JP .
CIRCULATION, 2002, 106 (12) :1505-1509
[29]   Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication [J].
Elam, MB ;
Heckman, J ;
Crouse, JR ;
Hunninghake, DB ;
Herd, JA ;
Davidson, M ;
Gordon, IL ;
Bortey, EB ;
Forbes, WP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1942-1947
[30]   Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects [J].
Faglia, E ;
Mantero, M ;
Caminiti, M ;
Caravaggi, C ;
De Giglio, R ;
Pritelli, C ;
Clerici, G ;
Fratino, P ;
De Cata, P ;
Dalla Paola, L ;
Mariani, G ;
Poli, M ;
Settembrini, PG ;
Sciangula, L ;
Morabito, A ;
Graziani, L .
JOURNAL OF INTERNAL MEDICINE, 2002, 252 (03) :225-232